March 1 (Reuters) - Perrigo Company Plc said on Monday it would sell its generic drugs business to private equity firm Altaris Capital Partners for a total consideration of $1.55 billion. (Reporting by Manas Mishra in Bengaluru; Editing by Sriraj Kalluvila)
مشاركة :